PCYC on NASDAQ

Pharmacyclics

Logo: Pharmacyclics, Public domain, via Wikimedia Commons4

American biopharmaceutical company

Pharmacyclics LLC is an American biopharmaceutical company based in Sunnyvale, California. It is primarily focused on the development of cancer therapies.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 19, 2026.

Overview

1991Founded1

Compare with another stock.

  • TickerPCYC on NASDAQ1
  • IndustryPharmaceutical Preparations1
  • HeadquartersSunnyvale1
  • Websitewww.pharmacyclics.com
  • Incorporated inDE5
  • Business addressPharmacyclics Inc, 995 E Arques Ave, Sunnyvale, Ca 94085-45215
  • Filer categoryLarge accelerated filer5

See how the biggest companies compare on our leaderboards

Pharmacyclics LLC is an American biopharmaceutical company based in Sunnyvale, California. It is primarily focused on the development of cancer therapies. In 2017, Xynomic Pharmaceuticals acquired all global rights to Abexinostat, Pharmacyclics' primary commercial product.3

Leadership

Who has led Pharmacyclics, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Richard A. Miller Md.2006–2008
  2. Robert W. Duggan2009–2015

Chair

  1. Robert W. Duggan2009–2015

President

  1. Glenn C. Rice2009

Chief financial officer

  1. Leiv Lea2006–2008
  2. Manmeet Singh Soni2014–2015

Chief operating officer

  1. Glenn C. Rice2009
  2. Maky Zanganeh2012–2015
1995200020052010201520202025
Board members and other officers (55)

Acquisitions

In March 2015, Chicago-based biopharmaceutical firm AbbVie announced it would acquire Pharmacyclics, as well as its lead anti-cancer compound ibrutinib (Imbruvica) for $21 billion. Imbruvica, the company’s flagship therapy, later became one of the most prescribed treatments for chronic lymphocytic leukemia (CLL). As part of the deal, AbbVie paid $261.25 per share in a mixture of both cash and AbbVie equity. The merger closed in mid-2015.

Duggan received over $3.55 billion from the sale of Pharmacyclics to AbbVie in "one of the biggest paydays ever from the buyout of a publicly held company."

From Wikipedia’s article on Pharmacyclics, shared under CC BY-SA 4.0.6

Timeline

  1. Aug 4, 2009New chief executive Robert W. Duggan becomes CEO7
  2. May 24, 2006New chief executive Richard A. Miller Md. becomes CEO8
  3. 1991Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65